Skip to content

Public FDA record

Z-1692-2024: Thoratec HeartMate 3, LVAS Implant Kit, REF:106524US, Sterile EO, RxOnly

Recall record Z-1692-2024 for Thoratec Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1692-2024
Company in FDA record
Thoratec Corp.
FDA classification date
May 1, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Potential for a leak path at the seal interface between the left ventricle assist system inflow cannula and the titanium apical cuff.

Source facts

Action
On March 20, 2024, Abbott issued a Urgent: Medical Device Correction Notification to affected consignee via E-Mail. Abbott asked consignees to take the following actions: 1. The product is not being removed from the field and unused product does not need to be returned. 2. If blood leak or air entrainment is suspected or observed, follow standard surgical processes and the existing IFU: 2a. Residual air must be completely evacuated from the device blood chamber prior to initiating the LVAD support. 2b.Ensure that bleeding is assessed and ensure proper management of hemostasis before closing all wounds. 2c. Use conventional strategies for resolving air leaks or surgical bleeding, including: adjusting the pump position, waiting for the natural tendency of blood to coagulate or upon reversal of anticoagulation, adding surgical materials, and exchanging the apical cuff, the pump, or both. 2d. Always have a complete backup system (implant kit and external components) available on-site and in close proximity during the implantation procedure for use in the event of an emergency. 3. Please distribute this notice to those who need to be aware within your institution and complete the attached acknowledgment form included with this letter and return it to Abbott at email: MCSHMNotices@abbott.com. Should you have any questions about this communication, please contact your local Abbott representative or call 612-346-3514.
Initiated
2024-03-01
Root cause
Device Design
Distribution
Worldwide Distribution: US (nationwide): AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, & WV; and OUS (foreign) countries of: Australia, Austria, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Cayman Islands, Chile, Colombia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, India, Iran, Iraq, Ireland, Israel, Italy, Japan, Kuwait, Lebanon, Lithuania, Macedonia, Malaysia, Martinique, Mexico, Morocco, Netherlands, New Zealand, Norway, Oman, Philippines, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, UK, United Arab Emirates, and Uzbekistan.
Recall number
Z-1692-2024
Recall status
Open, Classified
CDRH record ID
206613
FDA classified
2024-05-01
Recall event number
94232

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗